Exploring the association between the level of group 2 innate lymphiod cells in infarcted myocardium and the clinical prognosis

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2200056497

Enrollment

Unknown

Registered

2022-02-07

Start date

2022-03-01

Completion date

Unknown

Last updated

2024-10-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

myocardial infarction

Interventions

Case series:Nil

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. The ventricular aneurysm is larger or tends to increase gradually, which seriously affects the systolic function of the heart; 2. The ventricular aneurysm has a tendency to rupture or has ruptured, or itself is a pseudo-aneurysm formed after the rupture of the myocardial infarction area; 3. Combined with mural thrombosis or systemic embolism; 4. Repeated malignant arrhythmia, which is considered to be caused by abnormal electrical activity lesions formed by endomyocardial fibrosis in ventricular aneurysm; 5. Congestive heart failure; 6. The patients and their families agreed to participate in this study.

Exclusion criteria

Exclusion criteria: 1. Severe left ventricular dysfunction; 2. Pulmonary artery pressure greater than 60mmHg; 3. The risk of anesthesia is too great; 4. Patients or their families refuse to participate in this study.

Design outcomes

Primary

Measure	Time frame
Ejection Fraction;The association between the level of group 2 innate lymphiod cells in infarcted myocardium;	—

Secondary

Measure	Time frame
Cardiac color ultrasound;Electrocardiogram;	—

Countries

China

Contacts

Public ContactHe Bin

Shanghai Jiaotong University

bin_he@sjtu.edu.cn+86 18101930739

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026